Mackay Shields LLC’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-41,927
Closed -$1.05M 1288
2021
Q1
$1.05M Sell
41,927
-31,173
-43% -$778K 0.01% 981
2020
Q4
$1.99M Buy
73,100
+9,800
+15% +$267K 0.01% 856
2020
Q3
$1.17M Sell
63,300
-18,000
-22% -$332K 0.01% 980
2020
Q2
$1.66M Buy
81,300
+12,600
+18% +$257K 0.01% 841
2020
Q1
$1M Sell
68,700
-11,800
-15% -$172K 0.01% 945
2019
Q4
$1.14M Buy
80,500
+4,300
+6% +$61.1K 0.01% 1043
2019
Q3
$883K Buy
76,200
+300
+0.4% +$3.48K 0.01% 1143
2019
Q2
$1.53M Buy
75,900
+50,273
+196% +$1.01M 0.01% 1004
2019
Q1
$580K Buy
25,627
+4,700
+22% +$106K ﹤0.01% 1147
2018
Q4
$473K Sell
20,927
-2,173
-9% -$49.1K ﹤0.01% 1155
2018
Q3
$664K Buy
23,100
+4,100
+22% +$118K 0.01% 961
2018
Q2
$518K Buy
+19,000
New +$518K ﹤0.01% 1097